Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Galapagos (GB:0JXZ)
LSE:0JXZ
Holding GB:0JXZ?
Track your performance easily
0JXZ Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€21.82 - €38.98
Previous Close€26.03
Volume3.48K
Average Volume (3M)9.06K
Market Cap
€1.71B
Enterprise Value-€1.94B
Total Cash (Recent Filing)€3.68B
Total Debt (Recent Filing)€41.64M
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Feb 12, 2025EPS Estimate
-€0.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.33
Shares Outstanding65,835,511
10 Day Avg. Volume4,327
30 Day Avg. Volume9,062
Standard Deviation0.09
R-Squared0.00759
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.77
Price to Sales (P/S)5.62
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€32.00Price Target Upside22.95% Upside
Rating ConsensusHold
Number of Analyst Covering4
Galapagos News
PremiumCompany Announcements
Galapagos Unveils Promising Cancer Therapy Results
PremiumCompany Announcements
Galapagos Advances Cell Therapy and Financial GrowthPremiumCompany Announcements
Galapagos Appoints New Director for Growth Strategy
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
5.37% Mutual Funds
<0.01% Other Institutional Investors
91.90% Public Companies and
Individual Investors
0JXZ FAQ
What was Galapagos’s price range in the past 12 months?
Galapagos lowest share price was €21.82 and its highest was €38.98 in the past 12 months.
What is Galapagos’s market cap?
Currently, no data Available
When is Galapagos’s upcoming earnings report date?
Galapagos’s upcoming earnings report date is Feb 12, 2025 which is in 90 days.
How were Galapagos’s earnings last quarter?
Galapagos released its earnings results on Oct 30, 2024. The company reported -€0.75 earnings per share for the quarter, missing the consensus estimate of -€0.155 by -€0.595.
Is Galapagos overvalued?
According to Wall Street analysts Galapagos’s price is currently Undervalued.
Does Galapagos pay dividends?
Galapagos does not currently pay dividends.
What is Galapagos’s EPS estimate?
Galapagos’s EPS estimate is -€0.46.
How many shares outstanding does Galapagos have?
Galapagos has 65,897,070 shares outstanding.
What happened to Galapagos’s price movement after its last earnings report?
Galapagos reported an EPS of -€0.75 in its last earnings report, missing expectations of -€0.155. Following the earnings report the stock price went down -7.353%.
Which hedge fund is a major shareholder of Galapagos?
Currently, no hedge funds are holding shares in GB:0JXZ
---
Galapagos Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.40%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-6.27%
Trailing 12-Months
Company Description
Galapagos
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.
---
0JXZ Stock 12 Month Forecast
Average Price Target
€32.00
▲(22.95% Upside)
Technical Analysis
---